Vidasym Overview
- Year Founded
-
2009

- Status
-
Private
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$1.48M
- Investors
-
3
Vidasym General Information
Description
Operator of a clinical-stage company intended to cure chronic kidney disease. The company is developing small molecule drugs primarily for renal disorders, providing patients to get relief from diseases.
Contact Information
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- 2201 West Campbell Park Drive
- Suite 13
- Chicago, IL 60612
- United States
+1 (847) 000-0000
Vidasym Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
6. Grant | 01-Apr-2016 | $1.48M | 00.00 | Completed | Clinical Trials - General | |
5. Grant | 11-May-2015 | 0000 | 00.00 | Completed | Clinical Trials - General | |
4. Grant | 31-Aug-2014 | 00000 | 00.00 | Completed | Clinical Trials - General | |
3. Grant | 31-Aug-2013 | 00000 | 00.00 | Completed | Startup | |
2. Angel (individual) | $2.5M | $2.5M | Completed | Startup | ||
1. Angel (individual) | Completed | Startup |
Vidasym Patents
Vidasym Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2010236642-A1 | Vitamin d receptor agonists and uses thereof | Active | 17-Apr-2009 | 0000000000 | |
AU-2010236642-B2 | Vitamin d receptor agonists and uses thereof | Active | 17-Apr-2009 | 0000000000 | |
CA-2758698-A1 | Vitamin d receptor agonists and uses thereof | Active | 17-Apr-2009 | 0000000000 | |
CA-2758698-C | Vitamin d receptor agonists and uses thereof | Active | 17-Apr-2009 | 0000000000 | |
EP-2419403-A1 | Vitamin d receptor agonists and uses thereof | Active | 17-Apr-2009 | C07C401/00 |
Vidasym Executive Team (3)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Alan Lau | Founder & Interim Chief Executive Officer | ||
Ruth Wu-Wong Ph.D | Chief Scientific Officer & President |
Vidasym Investors (3)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
National Institutes of Health | Government | 000 0000 | 000000 0 | ||
U.S. Department of Health and Human Services | Government | 000 0000 | 000000 0 | ||
Alan Lau | Angel (individual) | Minority | 000 0000 | 000000 0 |